Co-Diagnostics Quick Ratio 2017-2024 | CODX
Historical quick ratio values for Co-Diagnostics (CODX) over the last 10 years.
| Co-Diagnostics Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2024-09-30 | $0.04B | $0.01B | 6.70 |
| 2024-06-30 | $0.05B | $0.01B | 8.81 |
| 2024-03-31 | $0.05B | $0.01B | 9.90 |
| 2023-12-31 | $0.06B | $0.01B | 10.52 |
| 2023-09-30 | $0.07B | $0.01B | 13.10 |
| 2023-06-30 | $0.07B | $0.01B | 14.21 |
| 2023-03-31 | $0.08B | $0.00B | 22.33 |
| 2022-12-31 | $0.09B | $0.00B | 22.57 |
| 2022-09-30 | $0.10B | $0.01B | 16.05 |
| 2022-06-30 | $0.11B | $0.01B | 16.36 |
| 2022-03-31 | $0.12B | $0.01B | 9.25 |
| 2021-12-31 | $0.11B | $0.01B | 8.98 |
| 2021-09-30 | $0.10B | $0.00B | 24.03 |
| 2021-06-30 | $0.09B | $0.01B | 18.23 |
| 2021-03-31 | $0.07B | $0.00B | 16.94 |
| 2020-12-31 | $0.06B | $0.00B | 14.72 |
| 2020-09-30 | $0.04B | $0.00B | 22.72 |
| 2020-06-30 | $0.03B | $0.00B | 8.98 |
| 2020-03-31 | $0.02B | $0.00B | 15.86 |
| 2019-12-31 | $0.00B | $0.00B | 4.23 |
| 2019-09-30 | $0.00B | $0.00B | 9.96 |
| 2019-06-30 | $0.01B | $0.00B | 14.59 |
| 2019-03-31 | $0.01B | $0.00B | 16.47 |
| 2018-12-31 | $0.00B | $0.00B | 0.44 |
| 2018-09-30 | $0.00B | $0.00B | 0.00 |
| 2018-06-30 | $0.00B | $0.00B | 0.00 |
| 2018-03-31 | $0.00B | $0.00B | 0.00 |
| 2017-12-31 | $0.00B | $0.00B | 7.07 |
| 2017-09-30 | $0.01B | $0.00B | 8.67 |
| 2017-06-30 | $0.00B | $0.01B | 0.00 |
| 2017-03-31 | $0.00B | 0.00 | |
| 2016-12-31 | $0.00B | 0.00 | |
| 2016-09-30 | $0.00B | 0.00 | |
| 2016-06-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.022B | $0.007B |
| Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $151.685B | 28.04 |
| Elevance Health (ELV) | United States | $90.559B | 11.84 |
| Cencora (COR) | United States | $47.572B | 17.32 |
| Natera (NTRA) | United States | $23.122B | 0.00 |
| DiDi Global (DIDIY) | China | $22.844B | 0.00 |
| ICON (ICLR) | Ireland | $16.164B | 14.40 |
| Avantor (AVTR) | United States | $14.769B | 22.14 |
| Revvity (RVTY) | United States | $14.502B | 24.32 |
| BioMerieux (BMXMF) | France | $14.256B | 0.00 |
| Viatris (VTRS) | United States | $13.010B | 4.01 |
| Solventum (SOLV) | United States | $12.919B | 0.00 |
| CochLear (CHEOY) | Australia | $12.848B | 0.00 |
| Medpace Holdings (MEDP) | United States | $11.220B | 31.61 |
| Doximity (DOCS) | United States | $10.877B | 56.56 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.037B | 0.00 |
| HealthEquity (HQY) | United States | $9.712B | 48.73 |
| Sonic Healthcare (SKHHY) | Australia | $8.513B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.502B | 16.43 |
| Amplifon S.p.A (AMFPF) | Italy | $6.136B | 31.28 |
| Bausch + Lomb (BLCO) | Canada | $5.661B | 26.33 |
| BrightSpring Health Services (BTSG) | United States | $3.913B | 83.22 |
| Sotera Health (SHC) | United States | $3.909B | 20.91 |
| Organon (OGN) | United States | $3.835B | 3.87 |
| Surgery Partners (SGRY) | United States | $3.260B | 37.17 |
| Concentras Parent (CON) | United States | $2.958B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.885B | 0.00 |
| PACS (PACS) | United States | $2.161B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.121B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.061B | 0.00 |
| Progyny (PGNY) | United States | $1.859B | 37.64 |
| GoodRx Holdings (GDRX) | United States | $1.837B | 48.20 |
| Premier (PINC) | United States | $1.821B | 11.08 |
| GeneDx Holdings (WGS) | United States | $1.708B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| Agilon Health (AGL) | United States | $1.351B | 0.00 |
| CareDx (CDNA) | United States | $1.217B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.177B | 11.51 |
| Embecta (EMBC) | United States | $1.031B | 7.06 |
| AMN Healthcare Services Inc (AMN) | United States | $0.993B | 6.72 |
| Establishment Labs Holdings (ESTA) | $0.848B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.602B | 0.00 |
| SBC Medicals (SBC) | United States | $0.533B | 0.00 |
| DocGo (DCGO) | United States | $0.501B | 18.89 |
| Sonida Senior Living (SNDA) | United States | $0.464B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.435B | 0.00 |
| Enhabit (EHAB) | United States | $0.414B | 35.83 |
| QDM (QDMI) | Hong Kong, SAR China | $0.382B | 10.00 |
| MultiPlan (MPLN) | United States | $0.352B | 0.00 |
| Nutex Health (NUTX) | United States | $0.323B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.317B | 0.00 |
| LifeMD (LFMD) | United States | $0.270B | 0.00 |
| Beauty Health (SKIN) | United States | $0.201B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.185B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.159B | 0.00 |
| Biodesix (BDSX) | United States | $0.151B | 0.00 |
| So-Young (SY) | China | $0.104B | 17.63 |
| Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.072B | 0.00 |
| Oncology Institute (TOI) | United States | $0.067B | 0.00 |
| ModivCare (MODV) | United States | $0.062B | 3.35 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
| OncoCyte (OCX) | United States | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.019B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| KindlyMD (KDLY) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |